Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Eli Lilly and Co's Remternetug?
Remternetug is a monoclonal antibody commercialized by Eli Lilly and Co, with a leading Phase III program in Alzheimer's Disease....
Data Insights
Risk adjusted net present value: What is the current valuation of Eli Lilly and Co's Remternetug?
Remternetug is a monoclonal antibody commercialized by Eli Lilly and Co, with a leading Phase III program in Alzheimer's Disease....